Latest filing published 17 Dec 2024 for Arcus Biosciences, Inc., €121k.
Insider track record
Dimitry SA Nuyten: trading record in brief
Dimitry SA Nuyten has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Arcus Biosciences, Inc. and Chinook Therapeutics, Inc. In total, 10 filings cover trades dated from 1 June 2020 to 15 December 2024.
The open-market record consists of 1 sale worth €7,596, with no purchase. Outside the open market, there are 6 share grants.
Most recently, on 17 December 2024, the filings show a share grant worth €121k in Arcus Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Dimitry SA Nuyten
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,856 shares@ US$16.0839.8% of flowCommon StockSEC:0001724521-24-000181:0
- 5,385 shares@ US$17.9528.8% of flowCommon StockSEC:0001724521-24-000149:0
- 28,000 shares0Common StockSEC:0001724521-24-000024:0
- 1,507 shares@ US$17.748.1% of flowCommon StockSEC:0001724521-23-000069:0
- 3,708 shares@ US$20.4023.3% of flowCommon StockSEC:0001724521-23-000008:0
- 34,000 shares0Common StockSEC:0001209191-23-004876:0
- 42,500 shares0Common StockSEC:0001209191-22-047316:0
7 of 7 declarations